Anticoagulants help control the adhering of platelets and stop clotting proteins from binding together. These are commonly used in the prevention and treatment of venous thrombosis, pulmonary embolism, and other conditions of blood clotting. Injectable anticoagulants are administered via different routes of injectable drug delivery and are categorized into direct thrombin inhibitors, factor Xa inhibitors, heparins, low-molecular-weight heparin (LMWH) including dalteparin, enoxaparin, and others. Heparin is an injectable anticoagulant widely used in hospitals for rapid anticoagulation. LMWHs are highly acceptable and preferred over heparins, as LMWHs can be self-administered when used in home settings, while heparins are large sized molecules and bleeding is associated with its use. Hence, these can only be injected at hospitals through skilled professionals.

According to the World Health Organization (WHO), prolonged traveling by passengers via automobile, train, or airplane for more than four hours increases the risk of developing venous thromboembolism. Coagulation disorders such as venous thromboembolism (VTE), which includes both deep vein thrombosis and pulmonary embolism, affect nearly 1 million people in the U.S. each year. According to the Centers for Disease Control and Prevention, 500,000 to 900,000 people in the U.S. are affected by VTE each year. A study published by Deutsches Arzteblatt International in 2013 revealed that the annual incidence rate of diagnosed VTE in Germany stood at 150 to 200 cases per 100,000. The statistics above clearly indicate the demand for safe, reliable, and affordable anticoagulants.

Rise in incidence of coagulation and renal and heart diseases, commercialization of safe and cost-effective biological origin anti-coagulants, enhanced quality control measures, increase in geriatric population, and surge in investment in research and development of biological origin drugs drive the market. High cost of treatment is the only factor restraining the market.

The global injectable anticoagulants market can be segmented based on drug type, application, and distribution channel. In terms of drug type, the market can be categorized into low-molecular-weight heparin (LMWH) and direct thrombin inhibitors (DTI). The low-molecular-weight heparin segment accounted for the largest market share and is expected to witness rapid growth during the forecast period. Based on application, the injectable anticoagulants market can be classified into venous thromboembolism (VTE), atrial fibrillation, acute coronary syndrome, and myocardial infarction. In terms of distribution channel, the global market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment accounted for the largest market share and the trend is likely to continue during the forecast period owing to rise in prevalence of deep vein thrombosis and increase in hospital inpatients for different disease treatments. This, in turn, is likely to drive the global injectable anticoagulants market during the forecast period.

Geographically, the global injectable anticoagulants market can be segmented into five major regions: North America, Middle East & Africa, Latin America, Asia Pacific, and Europe. North America is the leading market for injectable anticoagulants in terms of revenue, followed by Europe. The U.S. held the largest share of the market in North America, followed by Canada. The injectable anticoagulants market in Asia Pacific is likely to expand at a high CAGR during the forecast period. This is attributed to increase in patient population and rise in incidence of chronic diseases, which has led to high demand for injectable anticoagulant products.

Key players operating in the global injectable anticoagulants market include Sanofi, Genentech (Roche), Boehringer Ingelheim, Pfizer, The Medicines Company, B. Braun Melsungen AG, Baxter, Aspen Otsuka, Fresenius SE & Co. KGaA, LEO Pharma A/S, and Sagent Pharmaceuticals, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Injectable Anticoagulants Market